59 related articles for article (PubMed ID: 20552808)
1. [Pathogenetical and clinical features of the course of pyonecrotic complications of diabetic foot].
Petrova VV; Spesivtsev IuA; Larionova VI; Egorenkov MV; Smirnov GA; Remezov AV; Chub VIu
Vestn Khir Im I I Grek; 2010; 169(2):121-4. PubMed ID: 20552808
[No Abstract] [Full Text] [Related]
2. [Purulent and necrotic complications of diabetic foot syndrome and their reflection in ICD-10 and standards of insurance medicine].
Briskin BS; Dibirov MD; Khamiitov FF; Proshin AV; Iakovishvili IaI
Khirurgiia (Mosk); 2007; (1):49-54. PubMed ID: 17426690
[TBL] [Abstract][Full Text] [Related]
3. [Regional anesthesia and timely treatment for neuropathy in patients with pyonecrotic forms of the diabetic foot].
Orudzheva SA; Zviagin AA; Simonenkov AP; Tsvetkov VO; Kurochkina AI; Klenskiĭ SK; Braverman IB
Anesteziol Reanimatol; 2005; (2):35-7. PubMed ID: 15938094
[TBL] [Abstract][Full Text] [Related]
4. [Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].
Svetukhin AM; Zemlianoĭ AB; Orudzheva SA; Titova MI; Rudneva VG; Elagina LV; Pavlova MV; Terekhova RP; Bozh'eva EI; Makhmudova LS
Ter Arkh; 2001; 73(4):31-3. PubMed ID: 11494443
[TBL] [Abstract][Full Text] [Related]
5. [Surgical treatment of pyo-necrotic forms of diabetic foot].
Kucherovskiĭ OIu; Paramonov VE; Bykov VM; Morozov DN; Vlasov KE; Leonova NV
Khirurgiia (Mosk); 1999; (7):49-51. PubMed ID: 10459189
[TBL] [Abstract][Full Text] [Related]
6. [Substantiation and varieties of complex surgical treatment tactics for pyo-necrotic forms of diabetic foot].
Zemlianoĭ AB; Pal'tsyn AA; Svetukhin AM; Korotkina RN; Elagina LV; Pavlova MV; Terekhova RP; Kolokol'chikova EG; Bozh'eva EI; Makhmudova LS; Lebedeva AN; Ivanov LO
Khirurgiia (Mosk); 1999; (10):44-8. PubMed ID: 10540553
[TBL] [Abstract][Full Text] [Related]
7. [Hemostasis system disturbances and their correction in patients with pyonecrotic forms of diabetic foot].
Svetukhin AM; Amiraslanov IuA; Zemlianoĭ AB; Titiova MI; Istratov VG; Rudneva VG; Egorova VV; Korotkina RN; Terekhova RP; Doronina LP
Khirurgiia (Mosk); 2006; (10):30-4. PubMed ID: 17159864
[TBL] [Abstract][Full Text] [Related]
8. [Central hemodynamics during conduction anesthesia in patients with pyonecrotic forms of the diabetic foot].
Orudzheva SA; Zviagin AA; Kurochkina AI
Anesteziol Reanimatol; 2005; (3):15-7. PubMed ID: 16076038
[TBL] [Abstract][Full Text] [Related]
9. [Central hemodynamics during epidural anesthesia in patients with pyonecrotic forms of diabetic foot].
Orudzheva SA; Chistov AS; Zviagin AA; Sashurina LP
Anesteziol Reanimatol; 2002; (3):39-41. PubMed ID: 12221875
[TBL] [Abstract][Full Text] [Related]
10. [Surgical treatment of diabetic osteoarthropathy, complicated by pyogenic process in the feet].
Gostishchev VK; Afanas'ev AN; Khokhlov AM
Khirurgiia (Mosk); 1999; (8):40-4. PubMed ID: 10478530
[TBL] [Abstract][Full Text] [Related]
11. [ROLE OF ULTRASONIC CAVITATION IN COMPLEX TREATMENT OF SUPPURATIVE-NECROTIC COMPLICATIONS OF DIABETIC FOOT SYNDROME].
Petrenko OM
Klin Khir; 2015 Jul; (7):41-3. PubMed ID: 26591218
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers for atherosclerosis.
Ballantyne CM; Abe Y
J Cardiovasc Risk; 1997; 4(5-6):353-6. PubMed ID: 9865666
[No Abstract] [Full Text] [Related]
13. [Clinical classification of diabetic foot syndrome].
Shor NA
Klin Khir; 2011 Sep; (9):55-7. PubMed ID: 22168027
[TBL] [Abstract][Full Text] [Related]
14. Are postoperative complications genetically determined by TNF-beta NcoI gene polymorphism?
Kahlke V; Schafmayer C; Schniewind B; Seegert D; Schreiber S; Schröder J
Surgery; 2004 Apr; 135(4):365-73; discussion 374-5. PubMed ID: 15041959
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis and combined surgical treatment of the pyonecrotic diabetic foot].
Svetukhin AM; Zemlianoĭ AB; Istratov VG; Korotkina RN; Terekhova RP; Puchkova LS; Makhmudova LS
Khirurgiia (Mosk); 2003; (3):85-8. PubMed ID: 12698661
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma.
Yu C; Lu W; Tan W; Xing D; Liang G; Miao X; Lin D
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):176. PubMed ID: 12582032
[No Abstract] [Full Text] [Related]
17. Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis.
Stüve O; Korth C; Gabatto P; Cameron EM; Hu W; Eagar TN; Monson NL; Frohman EM; Racke MK; Zabetian CP; Oksenberg JR
Arch Neurol; 2009 Feb; 66(2):280-1. PubMed ID: 19204171
[No Abstract] [Full Text] [Related]
18. No association between OGG1 Ser326Cys polymorphism and breast cancer risk.
Vogel U; Nexø BA; Olsen A; Thomsen B; Jacobsen NR; Wallin H; Overvad K; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):170-1. PubMed ID: 12582029
[No Abstract] [Full Text] [Related]
19. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
20. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
